Please provide your email address to receive an email when new articles are posted on . Moderate to severe angiographic vasospasm was detected more often in controls than in those given implants.

October 1, 2010 (Las Vegas, Nevada) — The calcium-channel blocker nicardipine (Cardene, EKR Therapeutics) can rapidly achieve target blood pressure in patients in the emergency department with ...

The product is supplied in single-dose vials containing 25mg of nicardipine HCl in 10mL solution and is preservative free. According to the Company, it is available for immediate shipment.

Nicardipine is the generic name for the U.S ... the U.S., based on a variety of technologies like liquid injections in vials and pre-filled syringes, powder for injections and ophthalmic solutions ...

The mathematical significance of this study to predict nicardipine delivery using pharmacokinetic two-compartment mathematical model and linear ordinary differential equations approach represents a ...

"This is our seventeenth sterile product approval in the US based on a variety of technologies like liquid injections in vials and pre ... integrated into the Nicardipine API will also help ...

The coronary slow-flow phenomenon, defined as spontaneously delayed flow in the absence of obstructive coronary artery disease, can be effectively treated with the channel-channel blocker nicardipine, ...

FDA proposed in a Federal Register notice that bumetanide, nicardipine hydrochloride, and vasopressin should not be included on the list of bulk drug substances that outsourcing facilities may use in ...